Cargando…

Coagulation abnormalities & thromboprophylaxis in COVID-19

The ongoing pandemic of novel coronavirus 2019 is rapidly evolving, and newer organ- and system-specific manifestations are being observed. Thrombotic complications and coagulopathy are frequent manifestations of the disease, especially in sick patients, which appear to be unique and distinct from s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jandial, Aditya, Gupta, Anunay, Malviya, Amit, Agastam, Sourabh, Kumar, Dilip
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555598/ https://www.ncbi.nlm.nih.gov/pubmed/34643567 http://dx.doi.org/10.4103/ijmr.IJMR_3841_20

Ejemplares similares

Abnormally Enlarged Singular Thebesian Vein in Right Atrium
por: Kumar, Dilip, et al.
Publicado: (2021)

Chloroquine and hydroxychloroquine for COVID-19: time to close the chapter
por: Gupta, Anunay, et al.
Publicado: (2020)

Adenosine—A drug with myriad utility in the diagnosis and treatment of arrhythmias
por: Gupta, Anunay, et al.
Publicado: (2020)

Cardiovascular manifestations of COVID-19: An evidence-based narrative review
por: Sharma, Yash Paul, et al.
Publicado: (2021)

Thromboprophylaxis for children hospitalized with COVID‐19 and MIS‐C
por: Schmitz, Anna H., et al.
Publicado: (2022)

Chronic Marijuana Consumption Leading to High-Grade Atrioventricular Block in a Young Male
por: Malviya, Amit, et al.
Publicado: (2021)

Acute pulmonary embolism: An unseen villain in COVID-19
por: Agstam, Sourabh, et al.
Publicado: (2020)

Thromboprophylaxis in Pregnant Women with COVID-19: An Unsolved Issue
por: Varlas, Valentin Nicolae, et al.
Publicado: (2023)

Stroke and Thromboprophylaxis in the Era of COVID-19
por: Ma, Alice, et al.
Publicado: (2021)

Thromboprophylaxis in COVID-19 – Rationale and considerations
por: Bristogiannis, Sotirios, et al.
Publicado: (2021)

Coagulation abnormalities and thrombosis in patients with COVID-19
por: Levi, Marcel, et al.
Publicado: (2020)

Long COVID: pathophysiological factors and abnormalities of coagulation
por: Turner, Simone, et al.
Publicado: (2023)

Extended Thromboprophylaxis in Patients with COVID-19
por: Zhao, Wei, et al.
Publicado: (2021)

Thromboprophylaxis strategies for COVID-19 patients
por: Porres-Aguilar, Mateo, et al.
Publicado: (2022)

Thromboprophylaxis in Patients With Cancer and COVID-19
por: Lecumberri, Ramón, et al.
Publicado: (2022)

Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered?
por: Iba, Toshiaki, et al.
Publicado: (2021)

Continue ACE inhibitors / ARB’S till further evidence in coronavirus disease 2019 (COVID-19)
por: Bansal, Sandeep, et al.
Publicado: (2020)

Thromboprophylaxis strategies to improve the prognosis of COVID-19
por: Bertoletti, Laurent, et al.
Publicado: (2021)

Thromboprophylaxis for Coagulopathy Related to COVID-19 in Pediatrics: A Narrative Review
por: Sahrai, Hadi, et al.
Publicado: (2023)

Coagulation abnormalities in critically ill patients
por: Levi, Marcel, et al.
Publicado: (2006)

Pharmacologic therapeutic options for thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2020)

Thromboprophylaxis Strategies for Hospitalized Patients With COVID-19
por: Porres-Aguilar, Mateo, et al.
Publicado: (2022)

Current thromboprophylaxis in urological cancer patients during COVID-19 pandemic
por: Ostrowski, Adam, et al.
Publicado: (2022)

Hospital-based use of thromboprophylaxis in patients with COVID-19
por: Spyropoulos, Alex C, et al.
Publicado: (2020)

Coagulation Abnormalities Due to COVID-19 in a Child with Thalassemia
por: Marhaeni, Wulandewi, et al.
Publicado: (2021)

Lupus Anticoagulant and Abnormal Coagulation Tests in Patients with Covid-19
por: Bowles, Louise, et al.
Publicado: (2020)

Obstetric Thromboprophylaxis: The Swedish Guidelines
por: Lindqvist, Pelle G., et al.
Publicado: (2011)

Phosphatidylserine inside out: a possible underlying mechanism in the inflammation and coagulation abnormalities of COVID-19
por: Argañaraz, Gustavo A., et al.
Publicado: (2020)

Coagulation abnormalities and bleeding in pregnancy: an anesthesiologist’s perspective
por: Yoon, Hea-Jo
Publicado: (2019)

The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19
por: Kow, Chia Siang, et al.
Publicado: (2021)

Thromboses and COVID-19: reducing inflammation in addition to thromboprophylaxis
por: Mehta, Puja, et al.
Publicado: (2021)

Thromboprophylaxis in COVID-19: Anti-FXa—the Missing Factor?
por: Dutt, Tina, et al.
Publicado: (2020)

Thromboprophylaxis and anticoagulation for inpatients with COVID-19 in 2022 and beyond
por: Dalager-Pedersen, Michael
Publicado: (2022)

Biomarkers of Coagulation and Fibrinolysis during Cemented Total Hip Arthroplasty with Pre- versus Postoperative Start of Thromboprophylaxis
por: Borgen, Pål O., et al.
Publicado: (2013)

Perioperative thromboprophylaxis in liver transplant patients
por: De Pietri, Lesley, et al.
Publicado: (2018)

Enhanced thromboprophylaxis in critically ill patients with COVID-19 infection
por: Kummer, R.L., et al.
Publicado: (2021)

Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic
por: Marchandot, Benjamin, et al.
Publicado: (2020)

A Case With Inferior Wall Myocardial Infarction and Conduction Abnormalities: Addressing the Diagnostic Challenges
por: Bhasin, Dinkar, et al.
Publicado: (2022)

Coagulation Abnormalities Due to COVID-19 in a Child with Thalassemia: Correspondence
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Thromboprophylaxis in COVID‐19: Weight and severity adjusted intensified dosing
por: Engelen, Matthias M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_m3qok8n951d0ldhbc4rhb41osl